TREATMENT OF ECZEMA VACCINATUM WITH N-METHYLISATIN BETA-THIOSEMICARBAZONE
- 1 January 1966
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 287 (7427), 18-20
- https://doi.org/10.1016/s0140-6736(66)90006-7
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- CLINICAL EXPERIENCE WITH THE ANTIVIRAL DRUG MARBORAN® (1‐METHYLISATIN 3‐THIOSEMICARBAZONE) *Annals of the New York Academy of Sciences, 1965
- Eczema VaccinatumBMJ, 1964
- PROPHYLACTIC TREATMENT OF SMALLPOX CONTACTS WITH N-METHYLISATIN β-THIOSEMICARBAZONE (COMPOUND 33T57, MARBORAN)The Lancet, 1963
- Eczema VaccinatumBMJ, 1962
- Eczema Vaccinatum Treated with N-Methylisatin -ThiosemicarbazoneBMJ, 1962
- Drug for VacciniaBMJ, 1962
- Activity of p-Aminobenzaldehyde, 3-Thiosemicarbazone on Vaccinia Virus in the Chick Embryo and in the MouseExperimental Biology and Medicine, 1950